Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (38)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Cizman, M.
Right arrow Articles by Paragi, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cizman, M.
Right arrow Articles by Paragi, M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of Antimicrobial Chemotherapy (2001) 47, 475-477
© 2001 The British Society for Antimicrobial Chemotherapy


Brief report

The relationship between trends in macrolide use and resistance to macrolides of common respiratory pathogens

Milan Cizmana,*, Marko Pokorna, Katja Semeb, Andreja Orazemc and Metka Paragic

a Department of Infectious Diseases, University Medical Centre Ljubljana, Japljeva 2, SI-1525 Ljubljana; b Institute of Microbiology, Zaloska 4, SI-1525 Ljubljana; c Institute of Public Health of Slovenia, Trubarjeva 2, Ljubljana, Slovenia

The correlation between increased macrolide consumption and the resistance of Streptococcus pyogenes, Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis to macrolides in Slovenia from 1994 to 1999 was evaluated. The outpatient consumption of macrolides increased from 1.89 to 3.84 defined daily doses (DDD)/1000 inhabitants/day during the observation period. This increase in macrolide consumption was paralleled by a steady increase in macrolide resistance in S. pyogenes (from 0 to 7.4%, r = 0.90, P = 0.014) and upper respiratory S. pneumoniae isolates (from 0 to 9%, r = 0.82, P = 0.044). In other pathogens studied, no significant increase was detected.

* Corresponding author. Tel: +386-1-23-10-558; Fax: +386-1-23-02-781; E-mail: milan.cizman{at}mf.uni-lj.si


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Antimicrob. Agents Chemother.Home page
P. Karpanoja, S. T. Nyberg, M. Bergman, T. Voipio, P. Paakkari, P. Huovinen, H. Sarkkinen, and and the Finnish Study Group for Antimicrobial Resi
Connection between Trimethoprim-Sulfamethoxazole Use and Resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis
Antimicrob. Agents Chemother., July 1, 2008; 52(7): 2480 - 2485.
[Abstract] [Full Text] [PDF]


Home page
J. Bacteriol.Home page
C. W. Euler, P. A. Ryan, J. M. Martin, and V. A. Fischetti
M.SpyI, a DNA Methyltransferase Encoded on a mefA Chimeric Element, Modifies the Genome of Streptococcus pyogenes
J. Bacteriol., February 1, 2007; 189(3): 1044 - 1054.
[Abstract] [Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
C. Garcia-Rey, A. Fenoll, L. Aguilar, and J. Casal
Effect of social and climatological factors on antimicrobial use and Streptococcus pneumoniae resistance in different provinces in Spain
J. Antimicrob. Chemother., August 1, 2004; 54(2): 465 - 471.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
M. Green, J. M. Martin, K. A. Barbadora, B. Beall, and E. R. Wald
Reemergence of Macrolide Resistance in Pharyngeal Isolates of Group A Streptococci in Southwestern Pennsylvania
Antimicrob. Agents Chemother., February 1, 2004; 48(2): 473 - 476.
[Abstract] [Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
J. I. Alos, B. Aracil, J. Oteo, J. L. Gomez-Garces, and the Spanish Group for the Study of Infection in th
Significant increase in the prevalence of erythromycin-resistant, clindamycin- and miocamycin-susceptible (M phenotype) Streptococcus pyogenes in Spain
J. Antimicrob. Chemother., February 1, 2003; 51(2): 333 - 337.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
C. Garcia-Rey, L. Aguilar, F. Baquero, J. Casal, and J. E. Martin
Pharmacoepidemiological Analysis of Provincial Differences between Consumption of Macrolides and Rates of Erythromycin Resistance among Streptococcus pyogenes Isolates in Spain
J. Clin. Microbiol., August 1, 2002; 40(8): 2959 - 2963.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
S. Cresti, M. Lattanzi, A. Zanchi, F. Montagnani, S. Pollini, C. Cellesi, and G. M. Rossolini
Resistance Determinants and Clonal Diversity in Group A Streptococci Collected during a Period of Increasing Macrolide Resistance
Antimicrob. Agents Chemother., June 1, 2002; 46(6): 1816 - 1822.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
J. M. Martin, M. Green, K. A. Barbadora, and E. R. Wald
Erythromycin-Resistant Group A Streptococci in Schoolchildren in Pittsburgh
N. Engl. J. Med., April 18, 2002; 346(16): 1200 - 1206.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.